Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, Tanja Trarbach et al.|Journal of Clinical Oncology|2003Cited by 259